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K e y  M e s s a g e s 
1. Patients with obstructive sleep apnoea (OSA) 
had a number of neurocognitive deficits 
including attention lapses, working memory, 
verbal learning and recall, semantic fluency, and 
processing speed.
2. Psychological impairments including sleepiness 
and poor sleep quality, depressive, anxiety, and 
stress symptoms, poor functional outcomes and 
quality of life were noted in patients with OSA, 
compared with healthy controls.
3. This study serves as a potential first step in 
enhancing health care for patients with OSA 
in Hong Kong by establishing a neurocognitive 
Neurocognitive and psychosocial outcomes of 
obstructive sleep apnoea in Hong Kong Chinese
Introduction
Obstructive sleep apnoea (OSA) is the most 
common sleep disorder causing excessive daytime 
sleepiness, affecting 2% of females and 4% of males 
in the middle-aged workforce in Hong Kong.1,2 
This study aimed to investigate the functioning of 
individuals with OSA using a systematic paradigm 
of working memory, thereby establishing a cognitive 
and psychosocial profile of Hong Kong Chinese with 
OSA in comparison to western populations. 
Methods
Individuals aged 30 to 70 years who presented at the 
Sleep Disorders Centre of the Queen Mary Hospital 
with (1) a diagnosis of moderate to severe OSA 
(Apnea-Hypopnea Index [AHI] of ≥15 per hour) 
using standardised overnight polysomnography,3 
and (2) subjective symptoms of non-restorative sleep 
as indicated by excessive daytime sleepiness, fatigue, 
or functional impairment were recruited. Those who 
were excluded had (1) concurrent diagnoses of other 
sleep pathologies or significant medical condition 
or procedure (eg chronic obstructive pulmonary 
disease, active phase of cancers) or neurological 
disorder, past head injury with loss of consciousness, 
any other neurological conditions associated with 
cognitive impairment; (2) current alcohol or drug 
abuse (self-report); (3) a history of or current 
severe psychiatric illness that began >10 years 
before the diagnosis of OSA; and (4) current use of 
medication that could affect cognitive function (eg 
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psychotropics, benzodiazepines). 
 Age- and education-matched controls were 
recruited from the community. Those with the above 
exclusion criteria and (1) evidence of sleep pathology 
or disorder based on a clinical interview, and (2) 
evidence of having high risk for OSA as indicated 
by responses on the Berlin Questionnaire using the 
recommended cut-off score4 were excluded. 
 All participants filled out questionnaires of 
subjective sleep quality, sleepiness, and psychosocial 
measures, and were tested on the neurocognitive 
tests. All tests were conducted in Cantonese, and 
all translated tests had been validated in Chinese 
populations. 
 Daytime sleepiness was assessed using the self-
administered, 8-item Epworth Sleepiness Scale.5-7 
Sleep quality and disturbances over a 1-month 
interval was assessed using the self-rated Pittsburgh 
Sleep Quality Inventory.8 Neuropsychological 
tests9 and working memory tasks10 including the 
two storage systems: the phonological loop and 
visuospatial sketchpad, and the attentional controller 
(the central executive) were assessed; the verbal 
and spatial storage capacity of working memory 
was assessed using the Digit Span and Spatial Span 
of the Wechsler Memory Scale-Third Edition,11 
whereas the maintenance and online processing 
functioning of the central executive of working 
memory were assessed using a spatial n-back 
task.12,13 Mood symptoms were assessed using the 
21-item Depression Anxiety Stress Scales.14,15 The 
Profile of Mood States16 was used to separate somatic 
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and psychosocial profile and by identifying 
relevant daytime outcomes for treatment efficacy 
evaluation.
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symptoms (sleepiness, fatigue) from affective 
symptoms. The effects of sleep disturbances were 
assessed using the Functional Outcomes of Sleep 
Questionnaire.17 The sleep apnoea-specific health-
related quality of life was assessed using a validated 
Chinese version of the Calgary Sleep Apnea Quality 
of Life Index.18
 The OSA and control groups were compared 
using t-tests. A significance level of 0.01 was set to 
reduce type I error owing to multiple comparisons. 
Hierarchical regressions were used to explore 
predictors for neuropsychological outcomes.
Results
The OSA and control groups were comparable on age 
(t(53)=0.61, P=0.546), education level (t(53)=0.226, 
P=0.822), and gender ratio (χ2 (1)=4.771, P=0.041), 
but the OSA group had higher body mass index 
(t(32)=3.505, P=0.001), Epworth Sleepiness Scale 
score (t(53)=10.59, P<0.001), and Pittsburgh Sleep 
Quality Index global score (t(53)=2.632, P=0.011) 
[Table 1]. 
Neurocognitive functioning
Compared with healthy controls, patients with OSA 
had more (attention) lapses on the Psychomotor 
Vigilance Test, performed worse on the learning 
trials, immediate recall, and total recall of the Rey 
Auditory Verbal Learning Test, on the speed of 
naming colours and reading colour names of the 
Stroop Test, and on both semantic trials of the Fuld 
Verbal Fluency Test. For the working memory tasks, 
patients with OSA scored lower on the Backward 
Spatial Span, and had longer reaction times on the 
0-back condition of the spatial n-back task. The 
effect sizes (Cohen’s d) for all significant differences 
were large (>0.8) [Table 2].
Psychosocial functioning
Compared with healthy controls, patients with 
OSA had higher scores in all three subscales of the 
Depression Anxiety Stress Scales, higher fatigue-
inertia and more confusion-bewilderment on the 
Profile of Mood States, lower total score and all 
subscales on the Functional Outcomes of Sleep 
Questionnaire, and lower quality of life on the 
Calgary Sleep Apnea Quality of Life Index. The effect 
sizes (Cohen’s d) for all significant differences were 
very large (>1) [Table 3].
Predictors of neuropsychological functioning 
Hierarchical regression analyses were conducted 
to explore the predictors of neurocognitive and 
psychosocial functioning in the OSA group. None 
of the regression coefficients, including those of the 
demographic variables were significant (P>0.05). 
Discussion
Compared with healthy controls, patients with OSA 
performed significantly worse (with large effect 
sizes) on tasks of vigilance, working memory, verbal 
learning and recall, semantic fluency, and processing 
speed, but had comparable general intellectual 
functioning. These findings were consistent with 
those on western samples, except that the western 
samples had more pervasive deficits on working 
memory (2-back accuracies) and executive measures 
(eg Trail Making Test, Mazes) and less problems with 
verbal immediate recall.19-21 Nonetheless, our patients 
with OSA showed difficulties on the Backward 
Spatial Span, learning trials and semantic fluency on 
the Rey Auditory Verbal Learning Test, all of which 
require intact executive functioning. The lack of 
significant differences on other tests could be due 
to less exposure to psychological testing in general 
and computer tasks in the middle-aged population 
in Hong Kong, hence weaker performance in our 
healthy controls than western populations. 
 Patients with OSA showed higher level of 
depressive, anxiety, and stress symptoms, more 
fatigue and confusion, poorer functional outcomes, 
and lower quality of life. These findings concur 
TABLE 1.  Demographics and sleep variables of the obstructive sleep apnoea (OSA) 
and healthy control groups
Variable Mean±SD
OSA (n=25) Controls (n=30)
Age (years) 50.05±8.44 48.49±10.27
Education (years) 11.36±3.79 11.62±4.50
No. of females:males 4:21 13:17
Body mass index (kg/m2) 28.72±5.82* 23.43±5.26
Sleepiness (Epworth Sleepiness Scale) 16.88±4.11 5.77±3.67
Sleep Quality (Pittsburgh Sleep Quality Index)
Global score 7.12±3.63* 4.97±2.40
Subjective sleep quality 1.56±1.04 1.10±0.31
Sleep latency 0.80±0.91 0.97±0.72
Sleep duration 0.92±0.76 0.70±0.75
Sleep efficiency 0.92±1.29 0.53±0.86
Sleep disturbance 1.48±0.71 1.07±0.52
Daytime dysfunction 1.36±1.04* 0.60±0.56
Total sleep time (minutes) 406.08±42.76 -
Sleep efficiency (%) 82.27±8.71 -
% of stage 1 sleep 13.34±5.48 -
% of stage 2 sleep 59.66±11.89 -
% of stages 3 and 4 sleep 9.23±9.71 -
Apnea-Hypopnea Index 50.45±21.70 -
Minimum oxygen saturation 70.28±12.05 -
* P<0.01
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with those in western samples,22 and highlight the 
widespread psychological impact of OSA on patients 
without treatment.
 It is important to understand both the night-
time and daytime function of patients with OSA 
in order to make treatment decisions, optimise 
outcomes, and provide more precise information 
to health care providers, patients, and families 
regarding long-term prognosis of OSA.
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TABLE 2.  Neuropsychological outcomes of the obstructive sleep apnoea (OSA) and healthy control groups
Variable Mean±SD t(df=53) P value Effect size 
(d)
OSA group (n=25) Controls (n=30)
General intelligence
Raven’s Standard Progressive Matrices 43.87±9.23 45.53±12.43 0.538 0.593 -0.13 
Attention & working memory
Psychomotor Vigilance Test (PVT) mean response time (RT) [ms] 338.09±55.09 323.05±63.00 0.111 0.912 0.24 
PVT lapses (RT>3 sec) 3.84±4.91 0.13±0.34 3.989 <0.001 10.91 
Digit Vigilance Test (DVT) mean RT 355.38±121.4 321.50±51.85 1.376 0.175 0.65 
DVT errors 8.17±8.79 5.17±6.50 1.433 0.158 0.46 
Digit symbol 77.64±16.00 83.97±18.52 1.341 0.186 0.34 
Digit span forward 13.36±3.26 14.43±1.36 1.641 0.107 0.79 
Digit span backward 7.72±3.53 9.17±2.73 1.713 0.092 0.53 
Spatial span forward 8.28±2.39 9.70±2.18 2.301 0.025 0.65 
Spatial span backward 7.60±2.35 9.27±1.93 2.893 0.006 0.87 
Spatial 0-back RT (ms) 722.51±178.19 604.54±145.02 4.183 <0.001 0.81 
Spatial 0-back accuracy (%) 87.76±15.62 87.02±16.24 0.265 0.792 0.05 
Spatial 2-back RT (ms) 1057.49±260.09 953.43±279.48 1.634 0.109 0.37 
Spatial 2-back accuracy (%) 76.92±13.22 74.10±18.02 0.369 0.712 0.16 
Learning & memory
Rey Auditory Verbal Learning Test (RAVLT) learning trials 45.32±9.41 55.10±6.92 4.435 <0.001 1.41 
RAVLT immediate recall 9.60±2.63 12.17±2.98 3.350 0.001 0.86 
RAVLT delayed recall 8.68±3.02 11.67±2.81 3.793 <0.001 1.06 
Brief Visual Memory Test (BVMT)-R learning trials 21.65±6.33 24.33±6.41 1.518 0.135 0.42 
BVMT-R delayed recall 9.09±2.64 10.47±1.93 2.199 0.032 0.72 
Psychomotor dexterity
Grooved Pegboard Test: dominant 67.44±11.27 64.80±11.60 0.851 0.398 0.23 
Grooved Pegboard Test: non-dominant 72.40±12.37 71.93±14.60 0.126 0.900 0.03 
Executive functions
Color Trail Test 1 RT (sec) 41.83±24.43 36.52±16.13 1.355 0.181 0.33 
Color Trail Test 2 RT (sec) 78.07±23.80 76.52±31.90 0.201 0.841 0.05 
Fuld Verbal Fluency Test (FVFT) fruits and vegetables 19.35±5.67 23.4±4.46 2.909 0.005 0.91 
FVFT animals 17.74±3.80 21.87±5.88 2.925 0.005 0.70 
Stroop Color RT (sec) 14.24±3.36 11.91±2.26 3.065 0.003 1.03 
Stroop Word RT (sec) 18.44±5.93 14.69±3.21 2.980 0.004 1.17 
Stroop Color-word RT (sec) 29.85±10.11 25.43±7.83 1.826 0.074 0.56 
Wisconsin Card Sorting Test (WCST) categories 5.16±1.83 5.50±1.23 0.919 0.362 0.28 
WCST perseverative errors 13.92±12.54 11.93±11.29 0.618 0.539 0.18 
Mazes (Wechsler Intelligence Scale for Children III) 24.60±3.24 26.23±5.12 1.381 0.173 0.32 
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